Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Фармакотерапия головокружения - Справочник поликлинического врача №4 (2017)
Фармакотерапия головокружения
Чимагомедова А.Ш., Левин О.С. Фармакотерапия головокружения. Справочник поликлинического врача. 2017; 4: 45–50.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье представлены современные данные о клинической картине, подходах к диагностике и лечению разных форм как вестибулярного, так и невестибулярного головокружения. С позиций доказательной медицины рассмотрены сведения об эффективности вестибулосупрессивных средств, а также методов компенсации вестибулярной функции.
Ключевые слова: головокружение, вестибулопатии, нарушение равновесия, болезнь Меньера, бетагистин.
Key words: vertigo, dizziness, balance disorder, Meniere's disease, betahistine.
Ключевые слова: головокружение, вестибулопатии, нарушение равновесия, болезнь Меньера, бетагистин.
________________________________________________
Key words: vertigo, dizziness, balance disorder, Meniere's disease, betahistine.
Полный текст
Список литературы
1. Штульман Д.Р, Левин О.С. Неврология: справочник практического врача. 4-е изд. М: Медпресс-информ, 2005. / Shtul'man D.R, Levin O.S. Nevrologiia: spravochnik prakticheskogo vracha. 4-e izd. M: Medpress-inform, 2005. [in Russian]
2. Brandt T. Vertigo. In: Neurologic Disorders. Course and Treatment. Eds T.Brandt et al. San Diego, 1996; p. 117–34.
3. Bronstein A, Lempert T. Dizziness. Cambridge University Press, 2007.
4. Neuhauser HK, von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo. Neurology 2005; 65: 898–904.
5. Marchetti GF, Whitney SL. Older adults and balance dysfunction. Neurol Clin 2005; 23: 785–805.
6. Лавров А.Ю., Штульман Д.P., Яхно Н.Н. Головокpужение у пожилых. Неврологический журн. 2000; 5: 39–47. / Lavrov A.Iu., Shtul'man D.P., Iakhno N.N. Golovokpuzhenie u pozhilykh. Nevrologicheskii zhurn. 2000; 5: 39–47. [in Russian]
7. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107: 399–404.
8. Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med 1999; 341: 1590–6.
9. Baloh RW. Vestibular neuritis. N Engl J Med 2003; 348: 1027–32.
10. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand 1995; 43–8.
11. James A, Thorp M. Meniere’s disease. Clin Evid 2003; 9: 565–73.
12. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin 2005; 23: 831–53.
13. Eggers SDZ. Migraine-related vertigo. Curr Neurol Neurosci Reports 2006; 6: 106–15.
14. Jacob RG, Furman JM, Durrant JD et al. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996; 153: 503–12.
15. Neuhauser H, Leopold M, von Brevern M et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56: 436–41.
16. Лавров А.Ю. Применение бетасерка в неврологической практике. Неврологический журн. 2001; 2: 35–8. / Lavrov A.Iu. Primenenie betaserka v nevrologicheskoi praktike. Nevrologicheskii zhurn. 2001; 2: 35–8. [in Russian]
17. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85–100.
18. Swartz R, Longwell P. Treatment of vertigo. Am Fam Physician 2005; 71: 1115–29.
19. Albera R, Ciuffolotti R, Di Cicco M et al. Doubled-blind randomized multicenter study comparing the effect of betahistine and flunarisine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto-Laryngology 2003; 123: 588–93.
20. Schneider D, Kiessling B, Wieczorek M et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Therapeutics 2003; 41: 171–81.
21. Seipel JH, Fisher R, Blatchley RJ. Rheoencephalographic and other studies of betahistine in humans. J Clin Pharmacology 1977; 17: 140–61.
22. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2004; 3: CD003162.
23. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60–70.
24. Mira E, Guidetti G, Ghilardi L et al. Betahistine in the treatment of peripheral vestibular vertigo. Eur Arch Oto-Rhino-Laringology 2003; 260: 73–7.
25. James A, Burton MJ. Betahistine for Meniere disease or syndrome. Cochrane Database Syst Rev 2000; 3: CD001873.
26. Staab JP, Ruckenstein MJ, Solomon D et al. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg 2002; 128: 554–60.
2. Brandt T. Vertigo. In: Neurologic Disorders. Course and Treatment. Eds T.Brandt et al. San Diego, 1996; p. 117–34.
3. Bronstein A, Lempert T. Dizziness. Cambridge University Press, 2007.
4. Neuhauser HK, von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo. Neurology 2005; 65: 898–904.
5. Marchetti GF, Whitney SL. Older adults and balance dysfunction. Neurol Clin 2005; 23: 785–805.
6. Lavrov A.Iu., Shtul'man D.P., Iakhno N.N. Golovokpuzhenie u pozhilykh. Nevrologicheskii zhurn. 2000; 5: 39–47. [in Russian]
7. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107: 399–404.
8. Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med 1999; 341: 1590–6.
9. Baloh RW. Vestibular neuritis. N Engl J Med 2003; 348: 1027–32.
10. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand 1995; 43–8.
11. James A, Thorp M. Meniere’s disease. Clin Evid 2003; 9: 565–73.
12. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin 2005; 23: 831–53.
13. Eggers SDZ. Migraine-related vertigo. Curr Neurol Neurosci Reports 2006; 6: 106–15.
14. Jacob RG, Furman JM, Durrant JD et al. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996; 153: 503–12.
15. Neuhauser H, Leopold M, von Brevern M et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56: 436–41.
16. Lavrov A.Iu. Primenenie betaserka v nevrologicheskoi praktike. Nevrologicheskii zhurn. 2001; 2: 35–8. [in Russian]
17. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85–100.
18. Swartz R, Longwell P. Treatment of vertigo. Am Fam Physician 2005; 71: 1115–29.
19. Albera R, Ciuffolotti R, Di Cicco M et al. Doubled-blind randomized multicenter study comparing the effect of betahistine and flunarisine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto-Laryngology 2003; 123: 588–93.
20. Schneider D, Kiessling B, Wieczorek M et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Therapeutics 2003; 41: 171–81.
21. Seipel JH, Fisher R, Blatchley RJ. Rheoencephalographic and other studies of betahistine in humans. J Clin Pharmacology 1977; 17: 140–61.
22. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2004; 3: CD003162.
23. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60–70.
24. Mira E, Guidetti G, Ghilardi L et al. Betahistine in the treatment of peripheral vestibular vertigo. Eur Arch Oto-Rhino-Laringology 2003; 260: 73–7.
25. James A, Burton MJ. Betahistine for Meniere disease or syndrome. Cochrane Database Syst Rev 2000; 3: CD001873.
26. Staab JP, Ruckenstein MJ, Solomon D et al. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg 2002; 128: 554–60.
2. Brandt T. Vertigo. In: Neurologic Disorders. Course and Treatment. Eds T.Brandt et al. San Diego, 1996; p. 117–34.
3. Bronstein A, Lempert T. Dizziness. Cambridge University Press, 2007.
4. Neuhauser HK, von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo. Neurology 2005; 65: 898–904.
5. Marchetti GF, Whitney SL. Older adults and balance dysfunction. Neurol Clin 2005; 23: 785–805.
6. Лавров А.Ю., Штульман Д.P., Яхно Н.Н. Головокpужение у пожилых. Неврологический журн. 2000; 5: 39–47. / Lavrov A.Iu., Shtul'man D.P., Iakhno N.N. Golovokpuzhenie u pozhilykh. Nevrologicheskii zhurn. 2000; 5: 39–47. [in Russian]
7. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107: 399–404.
8. Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med 1999; 341: 1590–6.
9. Baloh RW. Vestibular neuritis. N Engl J Med 2003; 348: 1027–32.
10. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand 1995; 43–8.
11. James A, Thorp M. Meniere’s disease. Clin Evid 2003; 9: 565–73.
12. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin 2005; 23: 831–53.
13. Eggers SDZ. Migraine-related vertigo. Curr Neurol Neurosci Reports 2006; 6: 106–15.
14. Jacob RG, Furman JM, Durrant JD et al. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996; 153: 503–12.
15. Neuhauser H, Leopold M, von Brevern M et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56: 436–41.
16. Лавров А.Ю. Применение бетасерка в неврологической практике. Неврологический журн. 2001; 2: 35–8. / Lavrov A.Iu. Primenenie betaserka v nevrologicheskoi praktike. Nevrologicheskii zhurn. 2001; 2: 35–8. [in Russian]
17. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85–100.
18. Swartz R, Longwell P. Treatment of vertigo. Am Fam Physician 2005; 71: 1115–29.
19. Albera R, Ciuffolotti R, Di Cicco M et al. Doubled-blind randomized multicenter study comparing the effect of betahistine and flunarisine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto-Laryngology 2003; 123: 588–93.
20. Schneider D, Kiessling B, Wieczorek M et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Therapeutics 2003; 41: 171–81.
21. Seipel JH, Fisher R, Blatchley RJ. Rheoencephalographic and other studies of betahistine in humans. J Clin Pharmacology 1977; 17: 140–61.
22. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2004; 3: CD003162.
23. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60–70.
24. Mira E, Guidetti G, Ghilardi L et al. Betahistine in the treatment of peripheral vestibular vertigo. Eur Arch Oto-Rhino-Laringology 2003; 260: 73–7.
25. James A, Burton MJ. Betahistine for Meniere disease or syndrome. Cochrane Database Syst Rev 2000; 3: CD001873.
26. Staab JP, Ruckenstein MJ, Solomon D et al. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg 2002; 128: 554–60.
________________________________________________
2. Brandt T. Vertigo. In: Neurologic Disorders. Course and Treatment. Eds T.Brandt et al. San Diego, 1996; p. 117–34.
3. Bronstein A, Lempert T. Dizziness. Cambridge University Press, 2007.
4. Neuhauser HK, von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo. Neurology 2005; 65: 898–904.
5. Marchetti GF, Whitney SL. Older adults and balance dysfunction. Neurol Clin 2005; 23: 785–805.
6. Lavrov A.Iu., Shtul'man D.P., Iakhno N.N. Golovokpuzhenie u pozhilykh. Nevrologicheskii zhurn. 2000; 5: 39–47. [in Russian]
7. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107: 399–404.
8. Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med 1999; 341: 1590–6.
9. Baloh RW. Vestibular neuritis. N Engl J Med 2003; 348: 1027–32.
10. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand 1995; 43–8.
11. James A, Thorp M. Meniere’s disease. Clin Evid 2003; 9: 565–73.
12. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin 2005; 23: 831–53.
13. Eggers SDZ. Migraine-related vertigo. Curr Neurol Neurosci Reports 2006; 6: 106–15.
14. Jacob RG, Furman JM, Durrant JD et al. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996; 153: 503–12.
15. Neuhauser H, Leopold M, von Brevern M et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56: 436–41.
16. Lavrov A.Iu. Primenenie betaserka v nevrologicheskoi praktike. Nevrologicheskii zhurn. 2001; 2: 35–8. [in Russian]
17. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85–100.
18. Swartz R, Longwell P. Treatment of vertigo. Am Fam Physician 2005; 71: 1115–29.
19. Albera R, Ciuffolotti R, Di Cicco M et al. Doubled-blind randomized multicenter study comparing the effect of betahistine and flunarisine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto-Laryngology 2003; 123: 588–93.
20. Schneider D, Kiessling B, Wieczorek M et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Therapeutics 2003; 41: 171–81.
21. Seipel JH, Fisher R, Blatchley RJ. Rheoencephalographic and other studies of betahistine in humans. J Clin Pharmacology 1977; 17: 140–61.
22. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2004; 3: CD003162.
23. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60–70.
24. Mira E, Guidetti G, Ghilardi L et al. Betahistine in the treatment of peripheral vestibular vertigo. Eur Arch Oto-Rhino-Laringology 2003; 260: 73–7.
25. James A, Burton MJ. Betahistine for Meniere disease or syndrome. Cochrane Database Syst Rev 2000; 3: CD001873.
26. Staab JP, Ruckenstein MJ, Solomon D et al. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg 2002; 128: 554–60.
Авторы
А.Ш.Чимагомедова, О.С.Левин*
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
*oslevin@mail.ru
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
*oslevin@mail.ru
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
*oslevin@mail.ru
________________________________________________
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
*oslevin@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.